Target intelligence / Profile preview

RNA polymerase III subunit A (POLR3A)

Target
POLR3A
Molecular classification
Enzyme (DNA-dependent RNA polymerase), Catalytic subunit of multiprotein complex, Transcription factor (by function, but not classical DNA-binding TF)
01

Overview

RNA polymerase III subunit A (POLR3A) is the largest catalytic subunit of the human RNA polymerase III enzyme complex, which is crucial for the transcription of short, non-coding RNAs including all transfer RNAs (tRNAs), 5S ribosomal RNA, and several small nuclear RNAs involved in splicing and regulation[2][3][4][5]. POLR3A forms the catalytic core together with POLR3B and directly orchestrates the enzyme's polymerase activity by recognizing DNA templates and adding ribonucleotides to a growing RNA chain[4][5]. It is also involved in specialized cellular defense mechanisms, notably acting as a cytosolic DNA sensor in innate immune responses and participating in DNA repair[2][4]. Mutations in POLR3A cause distinct genetic syndromes including hypomyelinating leukodystrophy and progeroid syndrome, while dysregulation or enhanced activity is observed in various cancers, making it a potential target for therapeutic intervention, albeit with considerable risk due to its essential and ubiquitous cellular function[1][4][5][6].

Other names
DNA-directed RNA polymerase III subunit RPC1RNA polymerase III subunit C1RPC155RPC1hRPC155C160DNA-directed RNA polymerase III largest subunitRNA polymerase III 155 kDa subunitRNA polymerase III subunit C160ADDHHLD7WDRTSpolymerase (RNA) III (DNA directed) polypeptide A 155 kDapolymerase (RNA) III subunit A
02

Mechanism of action

Inhibitors would suppress Pol III transcriptional activity, reducing synthesis of tRNAs and 5S rRNA, thereby affecting protein translation and cellular proliferation—of potential use in cancer therapy

03

Biological functions

Transcription of small non-coding RNAs (tRNA, 5S rRNA, U6 snRNA)Protein synthesis (via tRNA and rRNA production)RNA processingRegulation of metabolic homeostasisInnate immunity (cytosolic DNA sensor, activation of RIG-I-dependent interferon response)DNA double-strand break repair (homologous recombination)Regulation of cell growth and proliferation
04

Disease associations

Hypomyelinating leukodystrophy (POLR3-related leukodystrophy)Wiedemann–Rautenstrauch syndrome (progeroid syndrome)Cancer (frequently upregulated in various cancers)Neurodegenerative disease (through leukodystrophy)Other developmental and neurological disorders
05

Safety considerations

Targeting may risk broad toxicity due to essential role in basic cellular functionsMutations or inhibition can lead to impaired protein synthesis, severe neurological disorders, and defects in cell growth
06

Interacting drugs

No approved direct-acting drugs are currently known; research efforts are ongoing for small molecule Pol III inhibitors

1 more in the full profile.

07

Biomarkers

Pathogenic mutations in POLR3A are diagnostic for hypomyelinating leukodystrophy and Wiedemann–Rautenstrauch syndromeAltered expression in cancer (potential biomarker for cancer cell proliferation)

Beyond the preview

Go deeper on RNA polymerase III subunit A (POLR3A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA polymerase III subunit A (POLR3A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call